Release Date: July 11, 2025
Expiration Date: July 11, 2026
Activity Overview
This educational activity is an archive of the live presentation held on May 31, 2025.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward hematologist-oncologists, medical oncologists, oncology nurses, NPs, PAs, and other HCPs involved in the treatment and management of MF, PV, and ET.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Analyze the latest data on current and emerging therapies for MF, PV, and ET
- Create an evidence-based treatment plan for a patient with MF, PV or ET that balances patient-, disease-, and treatment-related considerations
- Apply best practices for identifying and managing the AEs associated with treatment for MF, PV, and ET
- Implement supportive care approaches to address symptom burden in patients with MF, PV or ET
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login HereAccreditation/Credit Designation
Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.
Acknowledgment of Commercial Support
This activity is supported by educational grants from Geron, Incyte Corporation, and PharmaEssentia.
Physicians’ Education Resource® is proud to partner with the International Academy for Clinical Hematology
